Mediolanum International Funds’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Buy
11,620
+513
+5% +$190K 0.04% 294
2026
Q1
$3.16M Sell
11,107
-1,856
-14% -$610K 0.03% 314
2025
Q4
$4.52M Buy
12,963
+5,851
+82% +$1.98M 0.05% 274
2025
Q3
$2.27M Sell
7,112
-15,945
-69% -$4.96M 0.02% 329
2025
Q2
$8.8M Buy
23,057
+15,535
+207% +$6.25M 0.11% 194
2025
Q1
$3.25M Sell
7,522
-1,086
-13% -$436K 0.05% 291
2024
Q4
$3.17M Buy
8,608
+280
+3% +$117K 0.04% 282
2024
Q3
$4.36M Buy
8,328
+3,007
+57% +$1.61M 0.06% 263
2024
Q2
$2.66M Sell
5,321
-365
-6% -$193K 0.04% 279
2024
Q1
$2.96M Buy
+5,686
New +$2.83M 0.05% 261

Other funds holding ELV

Mediolanum International Funds's ELV Position: Q2 2026 in Review

Mediolanum International Funds increased its Elevance Health (ELV) stake by 4.6% in Q2 2026, buying an estimated $190K and bringing the position to 11,620 shares worth $4.51M. The position accounts for 0.04% of the portfolio, ranked #294.

Mediolanum International Funds first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.8M in Q2 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mediolanum International Funds held 11,620 shares of Elevance Health worth $4.51M as of Q2 2026.
  • Mediolanum International Funds bought 513 Elevance Health shares in Q2 2026, an estimated $190K.
  • Elevance Health made up 0.04% of Mediolanum International Funds's portfolio in Q2 2026, its #294 holding.
  • Mediolanum International Funds first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Elevance Health position peaked at $8.8M in Q2 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.